Wish you a very happy Thanksgiving day : )
Thursday, November 22, 2018
Thursday, August 23, 2018
No Evidence of Disease Activity after Five Years of Autologous Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Detailed Report of Five Patients
Background:: Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. Its treatment has focused on inflammation control as early as possible to avoid disability. Autologous hematopoietic stem cell transplantation (AHSCT) has been used for treating MS since 1996 without decisive results regarding benefits or long-term efficacy. We report the follow-up of five patients who were evaluated for up to five years after the stem cell transplantation treatment and who did not present any disease activity.
Methods: Five patients followed up at an MS center in Belo Horizonte, Brazil, who had relapsing-remitting MS with high disease activity, underwent AHSCT from 2009 to 2011. They were evaluated clinically, with magnetic resonance imaging, and by the Expanded Disability Status Scale, every six months and up to five years after transplantation.
Results: The patients in our study comprised four women and one man, with age ranging from 25 to 50 years, and time since disease onset ranging from 4 to 17 years at the time of the procedure. Four patients improved, one patient was stabilized, and all patients continued to be free of disease activity after 5 years.
Discussion:: Through improving patient selection and decreasing the time since disease onset, AHSCT could stop epitope spreading and disease progression. Despite multiple other therapeutic choices, AHSCT is a treatment to consider for aggressive MS disease.
Keywords: Stem cell; Autologous Transplant; Multiple Sclerosis Treatment; NEDA
Friday, September 2, 2016
Journal of Nutrition and Obesity
Dr. Katsunori Nonogaki is a specialist of Diabetes care and
Internal medicine. He received PhD in Endocrinology, Metabolism, and Diabetes
from Nagoya University Graduate School of Medicine, Japan. His research has mainly focused on “the role of the central
nervous system in the regulation of hepatic glucose production”.
Journal of Gastroenterology and Metabolism
Dr. Pia Munkholm currently working as a professor in the Department of Gastroenterology at the University Of Copenhagen, Denmark. She is a member of many gastroenterology associations i.e., American Gastroenterology Association as Fellow, Member of EC-IBD, European Collaborative study group of Inflammatory Bowel Disease. She has received several honors. She is serving as a referee for different international gastroenterology journals. She has many scientific publications and abstracts presented at international scientific meetings.
Click here to view the profile.
Click here to view the profile.
Click here to view our journal of Gastroenterology and Metabolism
Journal of Pediatric Disorders and Neonatal Care
Dr. Mirko Bertozzi is currently working as an Associate professor in the Department of Pediatric Surgery at S. Maria Della Misericordia Hospital in the University of Perugia, Italy. He received his Ph.D in Pediatric Surgery from the University of Bologna, Italy. He is an Executive board member for the Italian Society of Pediatric Video surgery –SIVI and he also serves as an associate member for Italian, European pediatric societies and Italian Group of Endoscopic Mini invasive Pediatric surgery.
Friday, June 3, 2016
A Case Report of Psychosis in a Patient of Myxedema: Myxedema Madness
Hypothyroidism is one of the most important causes of
organic psychosis and sometimes can be missed. There are some cases showing
extreme degree of hypothyroidism leading to psychiatric illnesses like mania,
depression and psychosis. In present case, a 21year old well-functioning female
developed hypothyroidism initially with symptoms of Myxedema which was
undiagnosed for 2 years. She had psychotic features after 2 years in form of
hallucinatory behavior, poor self-care, persecutory and referential delusions, episodes
of violent behavior and suicidal attempts. Thyroid supplementation was given in
therapeutic dose but there was no improvement in her clinical profile. It was
decided by experts to add antidepressant and antipsychotic medicines. Patient
had marked improvement. She started talking with family, her aggression
subsided. Only persecutory delusion and memory impairment persisted so doses of
antipsychotic medicine was gradually built up.
Click here to View Case Report Journal of Scholarena
Administration of Vasoconstrictor, But Not Volume Expander Prevents Maternal Hypotension During Spinal-Epidural Anesthesia For Elective Cesarean Section
Administration of vasoconstrictor preventing maternal
hypotension after combined spinal-epidural , anesthesia(CSEA) in elective
cesarean section patients.A total of 240 full-term, single pregnancy women,
undergoing elective cesarean section in CSEA were included. Multiple linear
regression analysis was used to identify major contributing factors for
maternal hypotension from 18 independent variables. The model was set as
αentry= 0.05, αremove = 0.15, and condition index <15. The incidence of
hypotension from different combinations of vasoconstrictors for hypotension
prevention were calculated and compared, then correlated with pH and base excess
in neonatal umbilical venous blood, as well as 1 and 5 min Apgar score, using
one-way ANOVA. p<0.05 was considered to be significant difference. Continuous
dosage of phenylephrine decrease incidence of maternal hypotension after CSEA
for elected cesarean section.
Subscribe to:
Posts (Atom)